Stemcell Holdings, Inc.
Other OTCTotal Valuation
Stemcell Holdings, Inc. carries a market capitalization of 1.64M, placing it among publicly traded companies globally.
| Market Cap | 1.64M |
| Enterprise Value | N/A |
Share Statistics
Stemcell Holdings, Inc. currently has 27.38M shares outstanding.
| Shares Outstanding | 27.38M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Stemcell Holdings, Inc. maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.66 |
| Quick Ratio | 1.46 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 67.34 |
| Return on Assets (ROA) | 34.90 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Stemcell Holdings, Inc. has paid 1.70M in income taxes, reflecting an effective tax rate of 35.42.
| Income Tax | 1.70M |
| Effective Tax Rate | 35.42 |
Stock Price Statistics
Stemcell Holdings, Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Stemcell Holdings, Inc. generated 9.98M in revenue and converted that into 3.10M in net income, yielding earnings per share of 0.11. EBITDA reached 4.98M, while operating income came in at 4.79M.
| Revenue | 9.98M |
| Gross Profit | 7.71M |
| Operating Income | 4.79M |
| Pretax Income | 4.80M |
| Net Income | 3.10M |
| EBITDA | 4.98M |
| EBIT | 4.79M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
Total book value stands at 6.13M, with working capital of 3.95M providing operational flexibility.
| Cash & Cash Equivalents | 5.12M |
| Total Debt | N/A |
| Net Debt | -5.12M |
| Equity (Book Value) | 6.13M |
| Book Value Per Share | 0.22 |
| Working Capital | 3.95M |
Cash Flow
Stemcell Holdings, Inc. produced 2.54M in operating cash flow over the past twelve months. After subtracting -434,665.00 in capital expenditures, free cash flow totaled 2.11M - equivalent to 0.08 per share.
| Operating Cash Flow | 2.54M |
| Capital Expenditures | -434,665.00 |
| Free Cash Flow | 2.11M |
| FCF Per Share | 0.08 |
Margins
Stemcell Holdings, Inc. operates with a gross margin of 77.19, reflecting its pricing power and cost economics. The operating margin of 48.03 and net profit margin of 31.04 provide insight into operational efficiency.
| Gross Margin | 77.19 |
| Operating Margin | 48.03 |
| Pretax Margin | 48.07 |
| Profit Margin | 31.04 |
| EBITDA Margin | 49.84 |
Scores
Stemcell Holdings, Inc. posts an Altman Z-Score of 3.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.25 |